radiotargeted gene therapy HSV1-tk (KIRAMS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameradiotargeted gene therapy HSV1-tk (KIRAMS)

Drug Alias Nameherpes simplex virus type 1 thymidine kinase and auger electron emitting nucleoside analog (KIRAMS)radiotargeted gene therapy HSV1-tk (Korea Institute of Radiological and Medical Sciences)

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive therapeutic agentCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKorea Institute Of Radiological And Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKorea Institute Of Radiological And Medical Sciences

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A